NeoPutty MTA

PreclinicalSmall molecule

OOctober University for Modern Sciences and Arts

NeoPutty MTA is one of 7 small molecule programs targeting Pulpotomy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PulpotomyNot yet recruiting

Primary TeethUnknown status

PulpotomyPreclinical

Not yet recruiting

Primary TeethPreclinical

Unknown status

Competition

Competitive Landscape

4 competitors in Primary Teeth

#DrugCompanyPhaseTrials

Mineral Trioxide Aggregate

JJordan University of Science and Technology

Phase 3

1 2

Silver Diamine Fluoride

TThe University of Hong Kong

Preclinical

2 3

NeoPutty MTA

OOctober University for Modern Sciences and Arts

Preclinical

1 4

Sodiumhexametaphosphate

MMinia University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pulpotomy1 trial

Clinical and Radiographic Assessment of Neo Putty MTA Versus Formocresol Used in Vital Pulpotomy of Mandibular Primary Molars

Not yet recruiting·OOctober University for Modern Sciences and Arts·N/A·NCT07437794·68 enrolled

Primary Teeth1 trial

Indirect Pulp Treatment in Primary Teeth

Unknown status·—·N/A·NCT04763057·88 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for NeoPutty MTA. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — NeoPutty MTA compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for NeoPutty MTA. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — October University for Modern Sciences and Arts company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: OOctober University for Modern Sciences and Arts

NeoPutty MTA

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pulpotomy1 trial

Primary Teeth1 trial

References

Drug Info

Quick Facts

Related News